{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:42:18Z","timestamp":1790422938632,"version":"4.1.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Food and Chemical Toxicology"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.fct.2016.07.005","type":"journal-article","created":{"date-parts":[[2016,7,12]],"date-time":"2016-07-12T19:30:44Z","timestamp":1468351844000},"page":"137-141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"special_numbering":"C","title":["Vanadium compounds for the treatment of human diabetes mellitus: A scientific curiosity? A review of thirty years of research"],"prefix":"10.1016","volume":"95","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6647-9470","authenticated-orcid":false,"given":"Jos\u00e9 L.","family":"Domingo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fct.2016.07.005_bib1","first-page":"19","article-title":"The lymphotoxic action of vanadate","volume":"11","author":"Al-Bayati","year":"1992","journal-title":"J.\u00a0Environ. Pathol. Toxicol. Oncol."},{"issue":"suppl. 1","key":"10.1016\/j.fct.2016.07.005_bib2","first-page":"39","article-title":"Genotoxic effects of vanadium compounds","volume":"39","author":"Altamirano-Lozano","year":"1998","journal-title":"Invest. Clin."},{"key":"10.1016\/j.fct.2016.07.005_bib3","series-title":"Akesis Pharmaceuticals Discontinues Sole Clinical Development Program and Announces Intent to File for Chapter 7 Bankruptcy","year":"2009"},{"key":"10.1016\/j.fct.2016.07.005_bib4","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/6103457","article-title":"Decavanadate toxicology and pharmacological activities: V10 or V1, both or none?","author":"Aureliano","year":"2016","journal-title":"Oxid. Med. Cell Longev."},{"key":"10.1016\/j.fct.2016.07.005_bib5","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1081\/CLT-100102425","article-title":"Vanadium","volume":"37","author":"Barceloux","year":"1999","journal-title":"J.\u00a0Toxicol. Clin. Toxicol."},{"key":"10.1016\/j.fct.2016.07.005_bib6","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1185\/03007995.2013.834250","article-title":"Increasing awareness of hypoglycaemia in patients with type 2 diabetes treated with oral agents","volume":"29","author":"Barnett","year":"2013","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.fct.2016.07.005_bib7","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.2174\/092986710793213805","article-title":"Potential use of vanadium compounds in therapeutics","volume":"17","author":"Barrio","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.fct.2016.07.005_bib8","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/BF00285328","article-title":"Effect of vanadate administration on blood glucose and insulin levels as well as on the exocrine pancreatic function in streptozotocin-diabetic rats","volume":"32","author":"Bendayan","year":"1989","journal-title":"Diabetologia"},{"key":"10.1016\/j.fct.2016.07.005_bib9","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/BF00265092","article-title":"In\u00a0vivo insulin resistance in streptozotocin-diabetic rats\u2013evidence for reversal following oral vanadate treatment","volume":"32","author":"Blondel","year":"1989","journal-title":"Diabetologia"},{"key":"10.1016\/j.fct.2016.07.005_bib10","first-page":"459","article-title":"Impaired insulin action but normal insulin receptor activity in diabetic rat liver: effect of vanadate","volume":"258","author":"Blondel","year":"1990","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.fct.2016.07.005_bib11","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/S0026-0495(96)90013-X","article-title":"Effects of vanadyl sulfate on carbohydrate and lipid metabolism in patients with non-insulin-dependent diabetes mellitus","volume":"45","author":"Boden","year":"1996","journal-title":"Metabolism"},{"key":"10.1016\/j.fct.2016.07.005_bib12","doi-asserted-by":"crossref","first-page":"386","DOI":"10.7326\/0003-4819-147-6-200709180-00178","article-title":"Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus","volume":"147","author":"Bolen","year":"2007","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.fct.2016.07.005_bib13","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/BF01075926","article-title":"Effects of vanadate on the expression of genes involved in fuel homeostasis in animal models of Type I and Type II diabetes","volume":"153","author":"Brichard","year":"1995","journal-title":"Mol. Cell Biochem."},{"key":"10.1016\/j.fct.2016.07.005_bib14","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1210\/endo-123-4-2048","article-title":"Long term improvement of glucose homeostasis by vanadate treatment in diabetic rats","volume":"123","author":"Brichard","year":"1988","journal-title":"Endocrinology"},{"key":"10.1016\/j.fct.2016.07.005_bib15","first-page":"435","article-title":"The insulin-like properties of vanadium: a curiosity or a perspective for the treatment of diabetes?","volume":"17","author":"Brichard","year":"1991","journal-title":"Diabete Metab."},{"key":"10.1016\/j.fct.2016.07.005_bib16","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0303-7207(93)90259-M","article-title":"Vanadate treatment of diabetic rats reverses the impaired expression of genes involved in hepatic glucose metabolism: effects on glycolytic and gluconeogenic enzymes, and on glucose transporter GLUT2","volume":"91","author":"Brichard","year":"1993","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.fct.2016.07.005_bib17","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1172\/JCI117951","article-title":"Oral vanadyl sulfate improves hepatic and peripheral insulin sensitivity in patients with non-insulin-dependent diabetes mellitus","volume":"95","author":"Cohen","year":"1995","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.fct.2016.07.005_bib18","first-page":"1234","article-title":"Classification of diabetes: an increasing heterogeneity","volume":"11","author":"Corcillo-Vionnet","year":"2015","journal-title":"Rev. Med. Suisse"},{"key":"10.1016\/j.fct.2016.07.005_bib19","first-page":"1410","article-title":"Vanadyl sulfate improves hepatic and muscle insulin sensitivity in type 2 diabetes","volume":"86","author":"Cusi","year":"2001","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.fct.2016.07.005_bib20","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/978-1-4614-5441-0_2","article-title":"Classification of diabetes","volume":"771","author":"De Faria-Maraschin","year":"2012","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.fct.2016.07.005_bib21","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0378-4274(98)00385-3","article-title":"Effect of age on vanadium nephrotoxicity in rats","volume":"105","author":"De la Torre","year":"1999","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.fct.2016.07.005_bib22","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1023\/A:1007067011338","article-title":"Vanadium and diabetes. What about vanadium toxicity?","volume":"203","author":"Domingo","year":"2000","journal-title":"Mol. Cell Biochem."},{"key":"10.1016\/j.fct.2016.07.005_bib23","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1385\/BTER:88:2:097","article-title":"Vanadium and tungsten derivatives as antidiabetic agents: a review of their toxic effects","volume":"88","author":"Domingo","year":"2002","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.fct.2016.07.005_bib24","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0890-6238(96)00019-6","article-title":"Vanadium: a review of the reproductive and developmental toxicity","volume":"10","author":"Domingo","year":"1996","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.fct.2016.07.005_bib25","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0300-483X(91)90199-B","article-title":"Oral vanadium administration to streptozotocin-diabetic rats has marked negative side-effects which are independent of the form of vanadium used","volume":"66","author":"Domingo","year":"1991","journal-title":"Toxicology"},{"key":"10.1016\/j.fct.2016.07.005_bib26","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1600-0773.1991.tb01233.x","article-title":"Improvement of glucose homeostasis by oral vanadyl or vanadate treatment in diabetic rats is accompanied by negative side effects","volume":"68","author":"Domingo","year":"1991","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.fct.2016.07.005_bib27","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/BF01075942","article-title":"Toxicology of vanadium compounds in diabetic rats: the action of chelating agents on vanadium accumulation","volume":"153","author":"Domingo","year":"1995","journal-title":"Mol. Cell Biochem."},{"key":"10.1016\/j.fct.2016.07.005_bib28","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0024-3205(93)90146-T","article-title":"Role of vanadium in nutrition: metabolism, essentiality and dietary considerations","volume":"52","author":"French","year":"1993","journal-title":"Life Sci."},{"key":"10.1016\/j.fct.2016.07.005_bib29","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1016\/S0021-9258(19)77957-5","article-title":"Insulin-like effects of vanadate on glucokinase activity and fructose 2,6-bisphosphate levels in the liver of diabetic rats","volume":"263","author":"Gil","year":"1988","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.fct.2016.07.005_bib30","first-page":"3311","article-title":"Metabolic effects of sodium metavanadate in humans with insulin-dependent and noninsulin-dependent diabetes mellitus in\u00a0vivo and in\u00a0vitro studies","volume":"80","author":"Goldfine","year":"1995","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.fct.2016.07.005_bib31","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0026-0495(00)90418-9","article-title":"Metabolic effects of vanadyl sulfate in humans with non-insulin-dependent diabetes mellitus: in\u00a0vivo and in\u00a0vitro studies","volume":"49","author":"Goldfine","year":"2000","journal-title":"Metabolism"},{"key":"10.1016\/j.fct.2016.07.005_bib32","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0162-0134(00)00035-0","article-title":"Insulin-like effects of vanadium: basic and clinical implications","volume":"80","author":"Goldwaser","year":"2000","journal-title":"J.\u00a0Inorg. Biochem."},{"key":"10.1016\/j.fct.2016.07.005_bib33","first-page":"603","article-title":"Essentiality and toxicity of vanadium supplements in health and pathology","volume":"65","author":"Gruzewska","year":"2014","journal-title":"J.\u00a0Physiol. Pharmacol."},{"key":"10.1016\/j.fct.2016.07.005_bib34","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2337\/diab.45.5.659","article-title":"Oral vanadyl sulfate improves insulin sensitivity in NIDDM but not in obese nondiabetic subjects","volume":"45","author":"Halberstam","year":"1996","journal-title":"Diabetes"},{"key":"10.1016\/j.fct.2016.07.005_bib35","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1126\/science.3156405","article-title":"Effect of vanadate on elevated blood glucose and depressed cardiac performance of diabetic rats","volume":"227","author":"Heyliger","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.fct.2016.07.005_bib36","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/MJT.0b013e3181afbf51","article-title":"Advances in the treatment of type 2 diabetes mellitus","volume":"18","author":"Israili","year":"2011","journal-title":"Am. J. Ther."},{"key":"10.1016\/j.fct.2016.07.005_bib37","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000175844","article-title":"Effect of vanadium on insulin sensitivity in patients with impaired glucose tolerance","volume":"53","author":"Jacques-Camarena","year":"2008","journal-title":"Ann. Nutr. Metab."},{"key":"10.1016\/j.fct.2016.07.005_bib38","doi-asserted-by":"crossref","DOI":"10.1007\/s12010-016-2137-1","article-title":"Effect of vanadyl rosiglitazone, a new insulin-mimetic vanadium complexes, on glucose homeostasis of diabetic mice","author":"Jiang","year":"2016","journal-title":"Appl. Biochem. Biotechnol."},{"key":"10.1016\/j.fct.2016.07.005_bib39","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.amepre.2012.04.017","article-title":"Diabetes prevention research: a systematic review of external validity in lifestyle interventions","volume":"43","author":"Laws","year":"2012","journal-title":"Am. J. Prev. Med."},{"key":"10.1016\/j.fct.2016.07.005_bib40","doi-asserted-by":"crossref","DOI":"10.1007\/s12272-016-0762-4","article-title":"Recent development of single preparations and fixed-dose combination tablets for the treatment of non-insulin-dependent diabetes mellitus : a comprehensive summary for antidiabetic drugs","author":"Li","year":"2016","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.fct.2016.07.005_bib41","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1385\/CBB:44:1:073","article-title":"Insulin signal mimicry as a mechanism for the insulin-like effects of vanadium","volume":"44","author":"Mehdi","year":"2006","journal-title":"Cell Biochem. Biophys."},{"key":"10.1016\/j.fct.2016.07.005_bib42","doi-asserted-by":"crossref","first-page":"6658","DOI":"10.1016\/S0021-9258(18)48292-0","article-title":"Oral administration of vanadate normalizes blood glucose levels in streptozotocin-treated rats. Characterization and mode of action","volume":"262","author":"Meyerovitch","year":"1987","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.fct.2016.07.005_bib43","first-page":"543","article-title":"Vanadium in mammalian physiology and nutrition","volume":"31","author":"Nielsen","year":"1995","journal-title":"Met. Ions Biol. Syst."},{"key":"10.1016\/j.fct.2016.07.005_bib44","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0300-483X(93)90096-B","article-title":"Vanadium treatment of diabetic Sprague-Dawley rats results in tissue vanadium accumulation and pro-oxidant effects","volume":"83","author":"Oster","year":"1993","journal-title":"Toxicology"},{"key":"10.1016\/j.fct.2016.07.005_bib45","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.2337\/diab.38.11.1390","article-title":"Long-term effects of vanadyl treatment on streptozocin-induced diabetes in rats","volume":"8","author":"Pederson","year":"1989","journal-title":"Diabetes"},{"key":"10.1016\/j.fct.2016.07.005_bib46","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jinorgbio.2015.11.004","article-title":"In\u00a0vitro effects of bis(1,2-dimethyl-3-hydroxy-4-pyridinonato)oxidovanadium(IV), or VO(dmpp)2, on insulin secretion in pancreatic islets of type 2 diabetic Goto-Kakizaki rats","volume":"154","author":"Pelletier","year":"2016","journal-title":"J.\u00a0Inorg. Biochem."},{"key":"10.1016\/j.fct.2016.07.005_bib47","first-page":"H904","article-title":"Oral vanadyl sulfate in treatment of diabetes mellitus in rats","volume":"257","author":"Ramanadham","year":"1989","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.fct.2016.07.005_bib48","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1039\/C4MT00304G","article-title":"The role of vanadium in biology","volume":"7","author":"Rehder","year":"2015","journal-title":"Metallomics"},{"key":"10.1016\/j.fct.2016.07.005_bib49","doi-asserted-by":"crossref","first-page":"325","DOI":"10.4155\/fmc.15.187","article-title":"Perspectives for vanadium in health issues","volume":"8","author":"Rehder","year":"2016","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.fct.2016.07.005_bib50","first-page":"35","article-title":"Vanadium distribution in rats and DNA cleavage by vanadyl complex: implication for vanadium toxicity and biological effects","volume":"102","author":"Sakurai","year":"1994","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.fct.2016.07.005_bib51","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/tcr.10029","article-title":"A\u00a0new concept: the use of vanadium complexes in the treatment of diabetes mellitus","volume":"2","author":"Sakurai","year":"2002","journal-title":"Chem. Rec."},{"key":"10.1016\/j.fct.2016.07.005_bib52","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0031-9384(97)00433-2","article-title":"Effects of vanadium on activity and learning in rats","volume":"63","author":"Sanchez","year":"1998","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.fct.2016.07.005_bib53","doi-asserted-by":"crossref","DOI":"10.2174\/0929867323666160321121138","article-title":"Why are antidiabetic vanadium complexes not in the pipeline of \u201cBig Pharma\u201d drug research? A critical review","author":"Scior","year":"2016","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.fct.2016.07.005_bib54","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1093\/qjmed\/hcn003","article-title":"A\u00a0systematic review of vanadium oral supplements for glycaemic control in type 2 diabetes mellitus","volume":"101","author":"Smith","year":"2008","journal-title":"QJM"},{"key":"10.1016\/j.fct.2016.07.005_bib55","first-page":"408","article-title":"Long- term efficacy and safety of vanadium in the treatment of type 1 diabetes","volume":"16","author":"Soveid","year":"2013","journal-title":"Arch. Iran. Med."},{"key":"10.1016\/j.fct.2016.07.005_bib56","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1517\/13543784.4.6.525","article-title":"Potential use of vanadium compounds in the treatment of diabetes mellitus","volume":"4","author":"Srivastava","year":"1995","journal-title":"Exp. Opin. Invest. Drugs"},{"key":"10.1016\/j.fct.2016.07.005_bib57","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1023\/A:1007075204494","article-title":"Anti-diabetic and toxic effects of vanadium compounds","volume":"206","author":"Srivastava","year":"2000","journal-title":"Mol. Cell Biochem."},{"key":"10.1016\/j.fct.2016.07.005_bib58","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1464-5491.2004.01381.x","article-title":"Insulino-mimetic and anti-diabetic effects of vanadium compounds","volume":"22","author":"Srivastava","year":"2005","journal-title":"Diabet. Med."},{"key":"10.1016\/j.fct.2016.07.005_bib59","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/j.jinorgbio.2006.08.016","article-title":"Vanadium in diabetes: 100 years from Phase 0 to Phase I","volume":"100","author":"Thompson","year":"2006","journal-title":"J.\u00a0Inorg. Biochem."},{"key":"10.1016\/j.fct.2016.07.005_bib60","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1039\/B513476E","article-title":"Metal complexes in medicinal chemistry: new vistas and challenges in drug design","volume":"14","author":"Thompson","year":"2006","journal-title":"Dalton Trans."},{"key":"10.1016\/j.fct.2016.07.005_bib62","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1043-2760(96)00262-7","article-title":"Vanadium compounds biological actions and potential as pharmacological agents","volume":"8","author":"Tsiani","year":"1997","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.fct.2016.07.005_bib63","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/6058705","article-title":"Metforminium decavanadate as a potential metallopharmaceutical drug for the treatment of diabetes mellitus","author":"Trevi\u00f1o","year":"2016","journal-title":"Oxid. Med. Cell Longev."},{"key":"10.1016\/j.fct.2016.07.005_bib64","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/S0140-6736(13)62219-9","article-title":"The many faces of diabetes: a disease with increasing heterogeneity","volume":"383","author":"Tuomi","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.fct.2016.07.005_bib65","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0162-0134(00)00226-9","article-title":"Effect of vanadium(IV) compounds in the treatment of diabetes: in\u00a0vivo and in\u00a0vitro studies with vanadyl sulfate and bis(maltolato)oxovandium(IV)","volume":"85","author":"Willsky","year":"2001","journal-title":"J.\u00a0Inorg. Biochem."},{"key":"10.1016\/j.fct.2016.07.005_bib66","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1039\/c3mt00162h","article-title":"Coordination chemistry may explain pharmacokinetics and clinical response of vanadyl sulfate in type 2 diabetic patients","volume":"5","author":"Willsky","year":"2013","journal-title":"Metallomics"},{"key":"10.1016\/j.fct.2016.07.005_bib67","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0742-8413(90)90040-G","article-title":"Some selected haematological indices in Wistar rats in the vanadium-ethanol interaction","volume":"96","author":"Zaporowska","year":"1990","journal-title":"Comp. Biochem. Physiol. C"},{"key":"10.1016\/j.fct.2016.07.005_bib68","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0742-8413(92)90199-H","article-title":"Haematological results of vanadium intoxication in Wistar rats","volume":"101","author":"Zaporowska","year":"1992","journal-title":"Comp. Biochem. Physiol. C"},{"key":"10.1016\/j.fct.2016.07.005_bib69","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/BF00154226","article-title":"Effect of chronic vanadium administration in drinking water to rats","volume":"6","author":"Zaporowska","year":"1993","journal-title":"Biometals"},{"key":"10.1016\/j.fct.2016.07.005_bib70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/15376516.2013.843110","article-title":"Vanadium carcinogenic, immunotoxic and neurotoxic effects: a review of in\u00a0vitro studies","volume":"24","author":"Zwolak","year":"2014","journal-title":"Toxicol. Mech. Methods"}],"container-title":["Food and Chemical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278691516302253?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278691516302253?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T21:29:07Z","timestamp":1759526947000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278691516302253"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":69,"alternative-id":["S0278691516302253"],"URL":"https:\/\/doi.org\/10.1016\/j.fct.2016.07.005","relation":{},"ISSN":["0278-6915"],"issn-type":[{"value":"0278-6915","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vanadium compounds for the treatment of human diabetes mellitus: A scientific curiosity? A review of thirty years of research","name":"articletitle","label":"Article Title"},{"value":"Food and Chemical Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fct.2016.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}